中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

Phio Pharmaceuticals Corp. (PHIO) Current Reports & Earnings Releases

View full earnings calendar →

Upcoming

FiledFormItemsFiling
2026-08-06 8-K Results of Operations, Financial Statements & Exhibits SEC
2026-07-21 8-K Officer / Director Changes, Other Events, Financial Statements & Exhibits SEC
2026-05-07 8-K Results of Operations, Financial Statements & Exhibits SEC
2026-04-08 8-K Material Agreement, Financial Statements & Exhibits SEC
2026-03-30 8-K Other Events SEC
2026-03-05 8-K Results of Operations, Financial Statements & Exhibits SEC
2026-02-18 8-K Officer / Director Changes SEC
2026-02-10 8-K Other Events, Financial Statements & Exhibits SEC
2026-01-20 8-K Other Events, Financial Statements & Exhibits SEC
2025-12-23 8-K Other Events, Financial Statements & Exhibits SEC
2025-11-25 8-K Other Events, Financial Statements & Exhibits SEC
2025-11-13 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-11-06 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-11-03 8-K Other Events, Financial Statements & Exhibits SEC
2025-10-31 8-K Officer / Director Changes, Other Events, Financial Statements & Exhibits SEC
2025-09-15 8-K Officer / Director Changes, Shareholder Vote Results SEC
2025-09-03 8-K Other Events, Financial Statements & Exhibits SEC
2025-08-14 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-07-30 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-07-25 8-K Other Events, Financial Statements & Exhibits SEC
2025-07-07 8-K Other Events SEC
2025-06-26 8-K Other Events, Financial Statements & Exhibits SEC
2025-06-12 8-K Officer / Director Changes, Financial Statements & Exhibits SEC
2025-05-15 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-05-07 8-K Other Events, Financial Statements & Exhibits SEC
2025-04-22 8-K Auditor Change, Financial Statements & Exhibits SEC
2025-04-09 8-K Other Events, Financial Statements & Exhibits SEC
2025-03-31 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-02-20 8-K Officer / Director Changes, Other Events, Financial Statements & Exhibits SEC
2025-01-17 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-01-15 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-01-14 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2025-01-13 8-K Other Events, Financial Statements & Exhibits SEC
2024-12-26 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2024-12-20 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2024-12-19 8-K Other Events, Financial Statements & Exhibits SEC
2024-11-14 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-11-07 8-K Other Events, Financial Statements & Exhibits SEC
2024-08-14 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-08-01 8-K Officer / Director Changes, Financial Statements & Exhibits SEC
2024-07-24 8-K Other Events SEC
2024-07-12 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2024-07-05 8-K Termination of Agreement, Other Events, Financial Statements & Exhibits SEC
2024-07-02 8-K Item 3.03, Charter Amendments, Other Events, Financial Statements & Exhibits SEC
2024-06-21 8-K Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits SEC
2024-05-28 8-K Other Events, Financial Statements & Exhibits SEC
2024-05-17 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2024-05-09 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-04-02 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-01-26 8-K Listing Notice SEC

Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.